Kemp Dolliver
Stock Analyst at Brookline Capital Markets
(2.14)
# 3,258
Out of 4,629 analysts
66
Total ratings
34.8%
Success rate
1.2%
Average return
Main Sectors:
Stocks Rated by Kemp Dolliver
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LNTH Lantheus Holdings | Downgraded: Hold | $100 → $105 | $100.95 | +4.01% | 2 | Jul 28, 2026 | |
| LSTA Lisata Therapeutics | Downgraded: Hold | n/a | $1.06 | - | 3 | Jul 27, 2026 | |
| TSXV: PINK Perimeter Medical Imaging AI, Inc. | Initiated Coverage: Buy | $1.54 | $0.33 | +373.85% | 1 | Jul 13, 2026 | |
| CLRB Cellectar Biosciences | Initiated Coverage: Buy | $15 | $2.57 | +483.66% | 1 | Jul 12, 2026 | |
| ICCM IceCure Medical | Maintained: Buy | $83 → $74 | $3.08 | +2,286.36% | 7 | Jun 17, 2026 | |
| RNTX Rein Therapeutics | Downgraded: Hold | n/a | $0.8175 | - | 4 | Jan 21, 2026 | |
| VRCA Verrica Pharmaceuticals | Upgraded: Buy | $17 | $5.08 | +234.65% | 4 | Dec 17, 2025 | |
| MNPR Monopar Therapeutics | Maintained: Buy | $52 → $93 | $119.21 | -21.99% | 2 | Sep 25, 2025 | |
| IBIO iBio, Inc. | Reiterated: Buy | $1.6 | $1.41 | +13.48% | 3 | Sep 5, 2025 | |
| BIOX Bioceres Crop Solutions | Downgraded: Hold | $24 → $26 | $0.3443 | +7,451.55% | 8 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 → $11 | $1.40 | +685.71% | 4 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $2.80 | n/a | 1 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $10.59 | n/a | 1 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $3.00 | n/a | 1 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.70 | n/a | 2 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $150 → $26 | $3.98 | n/a | 2 | Feb 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $31 | $1.02 | n/a | 2 | Jan 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.9501 | n/a | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0481 | n/a | 1 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $25 → $30 | $2.66 | n/a | 2 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $7 → $4.5 | $0.0003 | n/a | 6 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 → $23 | $8.09 | n/a | 3 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 1 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0012 | n/a | 1 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 1 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $5.27 | n/a | 1 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $5.24 | n/a | 1 | Oct 20, 2022 |
Lantheus Holdings
Jul 28, 2026
Downgraded: Hold
Price Target: $100 → $105
Current: $100.95
Upside: +4.01%
Lisata Therapeutics
Jul 27, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.06
Upside: -
Perimeter Medical Imaging AI, Inc.
Jul 13, 2026
Initiated Coverage: Buy
Price Target: $1.54
Current: $0.33
Upside: +373.85%
Cellectar Biosciences
Jul 12, 2026
Initiated Coverage: Buy
Price Target: $15
Current: $2.57
Upside: +483.66%
IceCure Medical
Jun 17, 2026
Maintained: Buy
Price Target: $83 → $74
Current: $3.08
Upside: +2,286.36%
Rein Therapeutics
Jan 21, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.8175
Upside: -
Verrica Pharmaceuticals
Dec 17, 2025
Upgraded: Buy
Price Target: $17
Current: $5.08
Upside: +234.65%
Monopar Therapeutics
Sep 25, 2025
Maintained: Buy
Price Target: $52 → $93
Current: $119.21
Upside: -21.99%
iBio, Inc.
Sep 5, 2025
Reiterated: Buy
Price Target: $1.6
Current: $1.41
Upside: +13.48%
Bioceres Crop Solutions
Aug 22, 2025
Downgraded: Hold
Price Target: $24 → $26
Current: $0.3443
Upside: +7,451.55%
Aug 18, 2025
Maintained: Buy
Price Target: $36 → $11
Current: $1.40
Upside: +685.71%
Jul 21, 2025
Initiated Coverage: Buy
Price Target: $18
Current: $2.80
Upside: n/a
Jul 9, 2025
Initiated Coverage: Buy
Price Target: $25
Current: $10.59
Upside: n/a
Mar 10, 2025
Initiated Coverage: Buy
Price Target: $11
Current: $3.00
Upside: n/a
Nov 15, 2024
Downgraded: Hold
Price Target: n/a
Current: $2.70
Upside: n/a
Feb 14, 2024
Maintained: Buy
Price Target: $150 → $26
Current: $3.98
Upside: n/a
Jan 24, 2024
Upgraded: Buy
Price Target: $31
Current: $1.02
Upside: n/a
Dec 19, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.9501
Upside: n/a
Dec 7, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.0481
Upside: n/a
Oct 31, 2023
Upgraded: Buy
Price Target: $25 → $30
Current: $2.66
Upside: n/a
Sep 5, 2023
Downgraded: Hold
Price Target: $7 → $4.5
Current: $0.0003
Upside: n/a
Jul 11, 2023
Initiated Coverage: Buy
Price Target: $19 → $23
Current: $8.09
Upside: n/a
May 25, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
May 1, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.0012
Upside: n/a
Jan 6, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Dec 16, 2022
Reiterated: Buy
Price Target: $13
Current: $5.27
Upside: n/a
Oct 20, 2022
Initiated Coverage: Buy
Price Target: $8
Current: $5.24
Upside: n/a